Table 3.
Salivary levels of amylase activity, chitinase activity, total protease activity (TPA), and albumin concentration measured by slope/min, dF/dT, slope/sec and U/mL, and µg/mL, respectively. Data are presented as the mean and standard deviation (sd) for the probiotic and placebo groups and p-values and confidence intervals (CI) are presented from comparison by groups performed on log10-transformed data via ANCOVA, with baseline values as covariate.
| Amylase Activity (slope/min) | Total Protease Activity (dF/dT) | Chitinase Activity (slope/s) | Albumin (µg/mL) | |
|---|---|---|---|---|
| Baseline | ||||
| Placebo mean (sd) | 0.04 (0.02) | 3.12 (0.24) | 0.35 (0.19) | 1.77 (0.3) |
| Probiotics mean (sd) | 0.04 (0.02) | 3.13 (0.22) | 0.3 (0.18) | 1.74 (0.25) |
| Day 14 | ||||
| Placebo mean (sd) | 0.04 (0.02) | 3.16 (0.27) | 0.31 (0.17) | 1.65 (0.26) |
| Probiotics mean (sd) | 0.04 (0.02) | 3.11 (0.23) | 0.27 (0.16) | 1.61 (0.6) |
| p -value (CI) | 0.87 | 0.25 | 0.72 | 0.63 |
| (−0.005; 0.007) | (−0.16; 0.04) | (−0.03; 0.05) | (−0.13; 0.08) | |
| Day 28 | ||||
| Placebo mean (sd) | 0.04 (0.02) | 3.17 (0.26) | 0.31 (0.16) | 1.68 (0.32) |
| Probiotics mean (sd) | 0.04 (0.02) | 3.11 (0.20) | 0.25 (0.16) | 1.54 (0.25) |
| p -value (CI) | 0.32 | 0.18 | 0.57 | 0.02 |
| (−0.003; 0.009) | (−0.15; 0.03) | (−0.05; 0.03) | (−0.23; −0.02) * |
* Significant differences between groups.